Inactivation of the Cyclin D-dependent Kinase in the Rat Fibroblast Cell Line, 3Y1, Induced by Contact Inhibition [PDF]
Akira Kato+3 more
openalex +1 more source
Autoantibody response towards chromatin in patients with juvenile idiopathic arthritis
Objective Juvenile idiopathic arthritis (JIA) patients frequently exhibit antinuclear antibodies (ANAs), but the specific antigen target recognized by them and the presence of additional autoantibody specificities in JIA patients remains elusive. Methods Plasma samples from 110 untreated patients with active JIA, as well as from 14 children with ...
Viola Pitkänen+13 more
wiley +1 more source
Focusing on cyclin-dependent kinases 5: A potential target for neurological disorders. [PDF]
Tian Z, Feng B, Wang XQ, Tian J.
europepmc +1 more source
Parathyroid Tumor Suppressor on 1p: Analysis of the p18 Cyclin-Dependent Kinase Inhibitor Gene As a Candidate [PDF]
Hideki Tahara+5 more
openalex +1 more source
The Cyclin-dependent Kinase Family
B Faha+4 more
openaire +2 more sources
Approaches to repurposing reverse transcriptase antivirals in cancer
This review highlights the role of reverse transcriptase (RT) inhibition in cellular regulation associated with non‐terminal repeat retrotransposons and endogenous retroviruses. Based on their pleiotropic characteristics, RT inhibitors (RTIs) are discussed as potential anticancer agents.
Richard Head+2 more
wiley +1 more source
Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes. [PDF]
Kokinos EK+11 more
europepmc +1 more source
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells.
Hiroaki Kiyokawa+3 more
openalex +1 more source
Identification of Substrate Binding Site of Cyclin-dependent Kinase 5 [PDF]
Pushkar Sharma+5 more
openalex +1 more source
Aims Clinical guidelines for breast cancer management have evolved in the past decade. However, limited evidence exists regarding uptake of novel drug classes in management of hormone receptor‐positive (HR+) metastatic breast cancer (MBC) in the USA and whether disparities exist by race and ethnicity.
Kexin Zhu+4 more
wiley +1 more source